Agilon Health Inc. (AGL) Reports In-Line Q2 EPS; lowers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
agilon health Inc (AGL) PT Lowered to $4 at Deutsche Bank
August 8, 2024 4:08 PM EDTDeutsche Bank analyst George Hill lowered the price target on agilon health Inc (NYSE: AGL) to $4.00 (from $5.00) while maintaining a Hold rating.
The analyst comments "Another Revenue Miss: AGL reported Q2 results missing at the revenue line but making it up with the better-than-expected adjusted EBITDA. AGL reported total revenue of $1.48B (+38% yoy), below the... More
